124 related articles for article (PubMed ID: 25869539)
1. Intravenous immunoglobulin use in septic shock patients after emergency laparotomy.
Tagami T; Matsui H; Fushimi K; Yasunaga H
J Infect; 2015 Aug; 71(2):158-66. PubMed ID: 25869539
[TBL] [Abstract][Full Text] [Related]
2. Intravenous immunoglobulin and mortality in pneumonia patients with septic shock: an observational nationwide study.
Tagami T; Matsui H; Fushimi K; Yasunaga H
Clin Infect Dis; 2015 Aug; 61(3):385-92. PubMed ID: 25882302
[TBL] [Abstract][Full Text] [Related]
3. Supplemental dose of antithrombin use in disseminated intravascular coagulation patients after abdominal sepsis.
Tagami T; Matsui H; Fushimi K; Yasunaga H
Thromb Haemost; 2015 Aug; 114(3):537-45. PubMed ID: 25948492
[TBL] [Abstract][Full Text] [Related]
4. Postoperative polymyxin B hemoperfusion and mortality in patients with abdominal septic shock: a propensity-matched analysis.
Iwagami M; Yasunaga H; Doi K; Horiguchi H; Fushimi K; Matsubara T; Yahagi N; Noiri E
Crit Care Med; 2014 May; 42(5):1187-93. PubMed ID: 24365858
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulation in sepsis-why blunting the response doesn't work?
Szakmany T; Heurich-Sevcenco M
J Infect; 2015 Aug; 71(2):147-9. PubMed ID: 25922288
[No Abstract] [Full Text] [Related]
6. Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis.
Laupland KB; Kirkpatrick AW; Delaney A
Crit Care Med; 2007 Dec; 35(12):2686-92. PubMed ID: 18074465
[TBL] [Abstract][Full Text] [Related]
7. Clinical experience with polyclonal IgM-enriched immunoglobulins in a group of patients affected by sepsis after cardiac surgery.
Buda S; Riefolo A; Biscione R; Goretti E; Cattabriga I; Grillone G; Bacchi-Reggiani L; Pacini D
J Cardiothorac Vasc Anesth; 2005 Aug; 19(4):440-5. PubMed ID: 16085247
[TBL] [Abstract][Full Text] [Related]
8. Impact of Intravenous Immunoglobulin on Survival in Necrotizing Fasciitis With Vasopressor-Dependent Shock: A Propensity Score-Matched Analysis From 130 US Hospitals.
Kadri SS; Swihart BJ; Bonne SL; Hohmann SF; Hennessy LV; Louras P; Evans HL; Rhee C; Suffredini AF; Hooper DC; Follmann DA; Bulger EM; Danner RL
Clin Infect Dis; 2017 Apr; 64(7):877-885. PubMed ID: 28034881
[TBL] [Abstract][Full Text] [Related]
9. Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study.
Linnér A; Darenberg J; Sjölin J; Henriques-Normark B; Norrby-Teglund A
Clin Infect Dis; 2014 Sep; 59(6):851-7. PubMed ID: 24928291
[TBL] [Abstract][Full Text] [Related]
10. Effect of intravenous immunoglobulin on the outcome of children with septic shock in a PICU: a retrospective cohort study.
Huang H; Chen J; Dang H; Liu C; Huo J; Fu YQ
Eur J Pediatr; 2023 Dec; 182(12):5315-5323. PubMed ID: 37733114
[TBL] [Abstract][Full Text] [Related]
11. Low-dose corticosteroid treatment and mortality in refractory abdominal septic shock after emergency laparotomy.
Tagami T; Matsui H; Fushimi K; Yasunaga H
Ann Intensive Care; 2015 Dec; 5(1):32. PubMed ID: 26514125
[TBL] [Abstract][Full Text] [Related]
12. IgMA-enriched immunoglobulin in neutropenic patients with sepsis syndrome and septic shock: a randomized, controlled, multiple-center trial.
Hentrich M; Fehnle K; Ostermann H; Kienast J; Cornely O; Salat C; Ubelacker R; Buchheidt D; Behre G; Hiddemann W; Schiel X
Crit Care Med; 2006 May; 34(5):1319-25. PubMed ID: 16540956
[TBL] [Abstract][Full Text] [Related]
13. Effects of low-dose intravenous immunoglobulin as the adjunctive therapy in septic shock patients with and without hypogammaglobulinemia: a retrospective cohort study.
Goto K; Yasuda N; Sato Y
Ann Palliat Med; 2022 Aug; 11(8):2600-2608. PubMed ID: 35695053
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic Antibiotics May Improve Outcome in Patients With Severe Burns Requiring Mechanical Ventilation: Propensity Score Analysis of a Japanese Nationwide Database.
Tagami T; Matsui H; Fushimi K; Yasunaga H
Clin Infect Dis; 2016 Jan; 62(1):60-6. PubMed ID: 26405146
[TBL] [Abstract][Full Text] [Related]
15. Effect of intravenous immunoglobulin for fulminant myocarditis on in-hospital mortality: propensity score analyses.
Isogai T; Yasunaga H; Matsui H; Tanaka H; Horiguchi H; Fushimi K
J Card Fail; 2015 May; 21(5):391-397. PubMed ID: 25639690
[TBL] [Abstract][Full Text] [Related]
16. Intravenous immunoglobulin for treating sepsis and septic shock.
Alejandria MM; Lansang MA; Dans LF; Mantaring JB
Cochrane Database Syst Rev; 2000; (2):CD001090. PubMed ID: 10796589
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Intravenous Immunoglobulin Therapy for Patients With Sepsis and Low Immunoglobulin G Levels: A Single-Center Retrospective Study.
Akatsuka M; Masuda Y; Tatsumi H; Sonoda T
Clin Ther; 2022 Feb; 44(2):295-303. PubMed ID: 35000795
[TBL] [Abstract][Full Text] [Related]
18. Intravenous immunoglobulin for adjunctive treatment of severe infections in ICUs.
Aubron C; Berteau F; Sparrow RL
Curr Opin Crit Care; 2019 Oct; 25(5):417-422. PubMed ID: 31335381
[TBL] [Abstract][Full Text] [Related]
19. The significance of immunoglobulins in the treatment of patients with sepsis and septic shock.
Bojić I; Begović V; Trnjak Z; Dokić M
Vojnosanit Pregl; 1998; 55(2 Suppl):75-8. PubMed ID: 9623363
[TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulin in children with streptococcal toxic shock syndrome.
Shah SS; Hall M; Srivastava R; Subramony A; Levin JE
Clin Infect Dis; 2009 Nov; 49(9):1369-76. PubMed ID: 19788359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
